Engaging community mental health stakeholders in pharmacy cost management

Psychiatric Services

Volumn 52, Issue 5, 2001, Pages 650-653

  Baker, J G ^a  

^a Magellan Behavioral Health of Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; BEHAVIOR THERAPY; COMMUNITY MENTAL HEALTH; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; EDUCATION; FEEDBACK SYSTEM; HEALTH CARE PLANNING; MANAGED CARE; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PUBLICATION;

COMMUNITY MENTAL HEALTH SERVICES; COMMUNITY-INSTITUTIONAL RELATIONS; DECISION MAKING; DRUG COSTS; FORMULARIES; GUIDELINES; HUMANS; MANAGED CARE PROGRAMS; MEDICAID; ORGANIZATIONAL CASE STUDIES; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; STATE HEALTH PLANS; TEXAS; UNITED STATES;

EID: 0035009079     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.5.650     Document Type: Article

References (22)

1. Just what the IIMO ordered: The paradox of increasing drug costs
2. Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
3. Economic comparisons of the pharmacotherapy of depression: An overview
4. Projecting future drug expenditures: 2000
5. Projecting future drug expenditures: 1999
6. A review of methods on drug cost management in hospitals
7. A multidisciplinary approach to hospital-based drug cost containment
8. New drugs and DTC advertising: Friend or foe?
9. Direct-to-consumer broadcast advertising: Empowering the consumer or manipulating a vulnerable population?
10. Medication cost information in a computer-based patient record system: Impact on prescribing in a family medicine clinical practice
11. Long-term pharmaceutical cost reduction using a data management system
12. The value of average wholesale pricing to the capitated physician provider
13. Financial incentives and drug spending in managed care
14. Improving cost-effectiveness of hypertension management at a community health centre
15. Evaluation of a computer-based decision support system for treatment of hypertension with drugs: Retrospective, nonintervention testing of cost and guideline adherence
16. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms
17. The Texas Medication Algorithm Project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder
18. Pharmacotherapy: Strategies to control drug costs in managed care
19. Pharmacoeconomics of treating uncomplicated urinary tract infections
20. Cost of treating mental illness from a managed care perspective
21. Economic outcomes of antipsychotic agents in a Medicaid population: Traditional agents vs risperidone
22. Modeling the pharmacoeconomic cost of three selective serotonin reuptake inhibitors